Design and protocol of Estrogenic Regulation of Muscle Apoptosis (ERMA) study with 47 to 55-year-old women's cohort : novel results show menopause-related differences in blood count
Abstrakti
Objective:
The multidisciplinary Estrogenic Regulation of Muscle Apoptosis (ERMA) study was designed to
reveal how hormonal differences over the menopausal stages affect the physiological and psychological functioning of middle-aged women. This paper describes the protocol and nonrespondent analysis of ERMA and novel findings on menopausal differences in blood count variables and their association with female sex hormones.
Methods:
Women aged 47 to 55 years were assigned to pre, early peri, late peri, and postmenopausal groups
based on follicle-stimulating hormone (FSH) and bleeding diary. Multivariate linear regression models were
constructed to estimate the association of 17b-estradiol (E2) and FSH with the blood count variables.
Results:
In all, 3,064 women returned the prequestionnaire (ERMA phase one), 1,393 donated blood samples and
were assigned to the relevant menopausal group (phase two), and 914 completed phase three, which included
physiological and psychological measurements. Nonrespondents were more likely than respondents to be obese,
whereas the menopausal groups showed no mean differences in body mass index. Blood count variables, while being
within clinical reference values, showed significant differences between groups. E2 and FSH were associated with
the white blood cell (WBC) count and neutrophil-to-lymphocyte ratio.
Conclusions:
The ERMA study was successful in recruiting and characterizing the menopausal status of a cohort
sample of middle-aged women. The significant group differences found in the blood count variables and their
associations with E2 and FSH verifies menopause-associated changes in WBC composition potentially being an
early sign of low-grade inflammation that may develop later in life.
Key Words:
17b-Estradiol – Blood viscosity – FSH – Leucocyte count – Menopausal status – Neutrophil-
to-lymphocyte ratio.
Päätekijät
Aineistotyyppi
Artikkelit
Tutkimusartikkeli
Julkaistu
2018
Sarja
Aiheet
Julkaisu tutkimustietojärjestelmässä
Julkaisija
Lippincott Williams & Wilkins
Julkaisun pysyvä osoite
https://urn.fi/URN:NBN:fi:jyu-201808223907Käytä tätä linkitykseen
Vertaisarvioinnin tila
Vertaisarvioitu
ISSN
1072-3714
DOI
https://doi.org/10.1097/GME.0000000000001117
Kieli
englanti
Julkaisussa
Menopause: The Journal of The North American Menopause Society
Viite
- Kovanen, V., Aukee, P., Kokko, K., Finni Juutinen, T., Tarkka, I., Tammelin, T., Kujala, U., Sipilä, S., & Laakkonen, E. (2018). Design and protocol of Estrogenic Regulation of Muscle Apoptosis (ERMA) study with 47 to 55-year-old women's cohort : novel results show menopause-related differences in blood count. Menopause: The Journal of The North American Menopause Society, 25(9), 1020-1032. https://doi.org/10.1097/GME.0000000000001117
Funder(s)
Euroopan komissio
Suomen Akatemia
Suomen Akatemia
Funding program(s)
MSCA Marie Skłodowska-Curie Actions, H2020
Akatemiahanke, SA
Akatemiatutkija, SA
MSCA Marie Skłodowska-Curie Actions, H2020
Academy Project, AoF
Academy Research Fellow, AoF


Euroopan unionin rahoittama. Esitetyt näkemykset ja mielipiteet ovat ainoastaan tämän tekstin laatijoiden näkemyksiä eivätkä välttämättä vastaa Euroopan unionin tai Euroopan koulutuksen ja kulttuurin toimeenpanovirasto (EACEA) kantaa. Euroopan unioni ja EACEA eivät ole vastuussa niistä.
Lisätietoja rahoituksesta
This research is supported by the Academy of Finland (VK: Grant nro 275323, EKL: nro 309504), PANINI (SS: Horizon 2020-the Framework Programme for Research and Innovation, Marie Sklodowska-Curie Actions, ITN, ref 15-0667), and the Juho Vainio Foundation (EKL). Financial disclosure/conflicts of interest: None reported.
Copyright© 2018 the Authors